Evidence for Shared Genetic Risk Between Methamphetamine-Induced Psychosis and Schizophrenia.

MLA

Ikeda, Masashi, et al. “Evidence for Shared Genetic Risk Between Methamphetamine-Induced Psychosis and Schizophrenia.” Neuropsychopharmacology, vol. 38, no. 10, Sept. 2013, pp. 1864–70. EBSCOhost, https://doi.org/10.1038/npp.2013.94.

APA

Ikeda, M., Okahisa, Y., Aleksic, B., Won, M., Kondo, N., Naruse, N., Aoyama-Uehara, K., Sora, I., Iyo, M., Hashimoto, R., Kawamura, Y., Nishida, N., Miyagawa, T., Takeda, M., Sasaki, T., Tokunaga, K., Ozaki, N., Ujike, H., & Iwata, N. (2013). Evidence for Shared Genetic Risk Between Methamphetamine-Induced Psychosis and Schizophrenia. Neuropsychopharmacology, 38(10), 1864–1870. https://doi.org/10.1038/npp.2013.94

Chicago

Ikeda, Masashi, Yuko Okahisa, Branko Aleksic, Mujun Won, Naoki Kondo, Nobuya Naruse, Kumi Aoyama-Uehara, et al. 2013. “Evidence for Shared Genetic Risk Between Methamphetamine-Induced Psychosis and Schizophrenia.” Neuropsychopharmacology 38 (10): 1864–70. doi:10.1038/npp.2013.94.